Professional Documents
Culture Documents
Anaphylactic
Anaphylactic
D I S E A S E
C O N T R O L
Treatment:
Call 911
ABCDs of resuscitation
Drugs (see Drug Administration Record)
Anaphylactic Shock
Treatment of Anaphylaxis
Note:
0.07 mL
0.07-0.1 mL
0.1-0.15 mL
0.15 mL
0.20 mL
0.30 mL
0.40 mL
0.50 mL
0.25 mL
0.50 mL
0.50 to 1.00 mL
1.00 mL
Time:
_______________________
Site:
_______________________
The above Drug Administration Record is to be reproduced and included in each anaphylaxis kit.
1 pocket mask
5 alcohol swabs
Sphygmomanometer (optional)
Stethoscope (optional)
Up to date contact information for the Public
Health Supervisor and Medical Officer(s) of
Health.
*Length of needle to be selected appropriate to patient size and body mass. Suggest: Needle gauge: 25G, needle
lenghts: 3 x 1; 3 x 5/8; 3 x 1.5
The kits can be stored at room temperature and should be closed with an elastic to ensure the drugs are not
exposed to light which can cause them to deteriorate. Additionally, the kits require regular verification to
replace drugs before the expiry date.
Call 911
ABCDs of resuscitation
Airway
Breathing
Circulation
Drugs
Other: Difficulty swallowing, abdominal pain, nausea, emesis, diarrhea, diaphoresis, apprehension
Vital Signs
Respiration
(rate/min.)
Pulse
(rate/min.)
Blood Pressure
Comments
The use of the Assessment Guide and Record is optional since it is expected a detailed incident report as per the
existing policies and procedures set out by the immunization providers employer/regional health authority; and
the Public Health Agency of Canada (PHAC) form for Adverse Event Following Immunization (AEFI) are to
be completed in the event of a suspect or actual anaphylaxis.
References:
Amercican Academy of Pediatrics. (2006). Red
Book. 2006 Report of the Committee on Infectious
Diseases. (27th ed.). Elk Grove Village, IL: Author.
British Columbia Communicable Disease Control
Immunization Manual. Anaphylaxis Section.
October 2006.
Canadian Pharmacists Association. (2007).
Compendium of Pharmaceuticals and Specialties.
The Canadian Drug Reference for Health
Professionals. Author.
Centers for Disease Control and Prevention. (2006).
General recommendations on immunization.
Recommendations of the Advisory Committee on
Immunization Practices. Morbidity and Mortality
Weekly Report, 55 (RR-15),1-48.
Ellis, A. K. and Day, J. H. (2003). Diagnosis and
management of anaphylaxis. Canadian Medical
Association Journal. 169 (4); 307-310.
Heart and Stoke Foundation. Manitoba Chapter.
Lieberman, P. (2003). Use of epinephrine in the
treatment of anaphylaxis. Current Opinion in Allergy
and Clinical Immunology, 3, 313-318.
Lieberman, P. (2006). Anaphylaxis. The Medical
Clinics of North America. 90 (2006), 77-95.